Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153913 | SCV000203528 | benign | not specified | 2014-01-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000153913 | SCV000309319 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000405665 | SCV000418354 | benign | Congenital Indifference to Pain | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000359605 | SCV000418356 | benign | Small fiber neuropathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000264835 | SCV000418357 | benign | Inherited Erythromelalgia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000360774 | SCV000418359 | benign | Paroxysmal extreme pain disorder | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000713172 | SCV000843752 | benign | not provided | 2018-05-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001513086 | SCV001720622 | benign | Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713172 | SCV001827479 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27884173, 17470132, 23129781) |
Genome- |
RCV001807103 | SCV002054602 | benign | Primary erythromelalgia | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807104 | SCV002054603 | benign | Channelopathy-associated congenital insensitivity to pain, autosomal recessive | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000360774 | SCV002054604 | benign | Paroxysmal extreme pain disorder | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000153913 | SCV005087318 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 83. Only high quality variants are reported. |
Genome Diagnostics Laboratory, |
RCV000153913 | SCV001930275 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000153913 | SCV001955998 | benign | not specified | no assertion criteria provided | clinical testing |